Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke. 2017

Xin-Wei He, and Wei-Ling Li, and Cai Li, and Peng Liu, and Yu-Guang Shen, and Min Zhu, and Xiao-Ping Jin
Department of Neurology, Taizhou Hospital, Wenzhou Medical University, Linhai, 317000, China.

The aim of this study was to assess the expression patterns of serum galectin-1 (Gal-1), galectin-3 (Gal-3), galectin-9 (Gal-9), and galectin-3 binding protein (Gal-3BP) and their associations with stroke outcome in large artery atherosclerotic (LAA) stroke. The serum levels of Gal-1, Gal-3, Gal-9, and Gal-3BP were measured by ELISA in 130 patients with LAA stroke and 130 age- and sex-matched controls. Serum samples were collected from the patients on day 1, day 6, and in the 4th week after ischaemic stroke (IS). An unfavourable outcome was defined as a modified Rankin Scale score of >2 on day 90 after IS. Our results indicated that the Gal-3 and Gal-9 levels were higher in patients with LAA stroke than in controls. A higher Gal-3 level was independently associated with an unfavourable outcome both on day 1 and day 6 after IS. In addition, Gal-9 and Gal-1 levels were upregulated on day 6 and in the 4th week after IS, respectively. For Gal-3BP, no difference was detected between patients and controls and no predictive value was found in patients. In conclusion, these findings suggest that the serum levels of Gal-1, Gal-3, and Gal-9 may be associated with LAA stroke.

UI MeSH Term Description Entries
D008297 Male Males
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers

Related Publications

Xin-Wei He, and Wei-Ling Li, and Cai Li, and Peng Liu, and Yu-Guang Shen, and Min Zhu, and Xiao-Ping Jin
January 2015, Mediators of inflammation,
Xin-Wei He, and Wei-Ling Li, and Cai Li, and Peng Liu, and Yu-Guang Shen, and Min Zhu, and Xiao-Ping Jin
March 2021, Aging,
Xin-Wei He, and Wei-Ling Li, and Cai Li, and Peng Liu, and Yu-Guang Shen, and Min Zhu, and Xiao-Ping Jin
October 2019, Allergy,
Xin-Wei He, and Wei-Ling Li, and Cai Li, and Peng Liu, and Yu-Guang Shen, and Min Zhu, and Xiao-Ping Jin
January 2016, The International journal of neuroscience,
Xin-Wei He, and Wei-Ling Li, and Cai Li, and Peng Liu, and Yu-Guang Shen, and Min Zhu, and Xiao-Ping Jin
October 2012, Nature genetics,
Xin-Wei He, and Wei-Ling Li, and Cai Li, and Peng Liu, and Yu-Guang Shen, and Min Zhu, and Xiao-Ping Jin
August 2018, Clinical neurology and neurosurgery,
Xin-Wei He, and Wei-Ling Li, and Cai Li, and Peng Liu, and Yu-Guang Shen, and Min Zhu, and Xiao-Ping Jin
August 2023, Translational stroke research,
Xin-Wei He, and Wei-Ling Li, and Cai Li, and Peng Liu, and Yu-Guang Shen, and Min Zhu, and Xiao-Ping Jin
March 2008, Neurology,
Xin-Wei He, and Wei-Ling Li, and Cai Li, and Peng Liu, and Yu-Guang Shen, and Min Zhu, and Xiao-Ping Jin
August 2020, Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999),
Xin-Wei He, and Wei-Ling Li, and Cai Li, and Peng Liu, and Yu-Guang Shen, and Min Zhu, and Xiao-Ping Jin
January 2019, Disease markers,
Copied contents to your clipboard!